P. Sullivan

发表

Determination of HIV status and identification of incident HIV infections in a large, community‐randomized trial: HPTN 071 (PopART)

O. Laeyendecker, H. Ayles, D. Donnell, 2020, Journal of the International AIDS Society.

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.

T. Holtz, C. del Rio, E. Daar, 2021, The New England journal of medicine.

Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.

S. Delany-Moretlwe, C. Petropoulos, J. Mellors, 2022, The Journal of infectious diseases.

Connecting Youth and Young Adults to Optimize ART Adherence (YouTHrive): Protocol for a Randomized Controlled Trial (Preprint)

R. MacLehose, L. Hightow-Weidman, K. Horvath, 2018 .